Puma Biotechnology Inc (PBYI)
5.18
+0.17
(+3.39%)
USD |
NASDAQ |
Apr 22, 16:00
5.18
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Free Cash Flow (Quarterly): 10.41M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.41M |
| September 30, 2023 | 10.59M |
| June 30, 2023 | 3.228M |
| March 31, 2023 | -9.857M |
| December 31, 2022 | 7.683M |
| September 30, 2022 | 17.26M |
| June 30, 2022 | -13.87M |
| March 31, 2022 | -26.90M |
| December 31, 2021 | -5.435M |
| September 30, 2021 | 10.50M |
| June 30, 2021 | -0.074M |
| March 31, 2021 | 15.66M |
| December 31, 2020 | -5.658M |
| September 30, 2020 | 1.709M |
| June 30, 2020 | 6.216M |
| March 31, 2020 | -11.54M |
| December 31, 2019 | 1.566M |
| September 30, 2019 | -7.307M |
| June 30, 2019 | 44.25M |
| March 31, 2019 | -16.13M |
| December 31, 2018 | 6.988M |
| September 30, 2018 | -7.567M |
| June 30, 2018 | -17.84M |
| March 31, 2018 | -6.293M |
| December 31, 2017 | -85.75M |
| Date | Value |
|---|---|
| September 30, 2017 | -55.06M |
| June 30, 2017 | -45.92M |
| March 31, 2017 | -36.17M |
| December 31, 2016 | -41.52M |
| September 30, 2016 | -34.96M |
| June 30, 2016 | -37.43M |
| March 31, 2016 | -35.07M |
| December 31, 2015 | -33.09M |
| September 30, 2015 | -37.02M |
| June 30, 2015 | -34.90M |
| March 31, 2015 | -50.64M |
| December 31, 2014 | -19.09M |
| September 30, 2014 | -24.45M |
| June 30, 2014 | -17.69M |
| March 31, 2014 | -17.26M |
| December 31, 2013 | -13.77M |
| September 30, 2013 | -12.09M |
| June 30, 2013 | -11.15M |
| March 31, 2013 | -18.66M |
| December 31, 2012 | -25.20M |
| September 30, 2012 | -7.653M |
| June 30, 2012 | -9.015M |
| March 31, 2012 | -3.208M |
| December 31, 2011 | -2.330M |
| September 30, 2011 | -0.1432M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-26.90M
Minimum
Mar 2022
44.25M
Maximum
Jun 2019
2.549M
Average
1.709M
Median
Sep 2020
Free Cash Flow (Quarterly) Benchmarks
| ADMA Biologics Inc | 16.19M |
| Regeneron Pharmaceuticals Inc | 776.20M |
| Sarepta Therapeutics Inc | -73.70M |
| CytomX Therapeutics Inc | -22.23M |
| Mirum Pharmaceuticals Inc | -21.62M |